title: Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
abstract: Osteoclasts (OCs), which form by fusion of hematopoietic precursor cells, are typically present in large numbers in giant cell tumors of bone (GCTBs). These tumors may, therefore, contain cells which secrete factors that stimulate recruitment and differentiation of OC precursors. Multinucleated cells resembling OCs also form in cultures of human cord blood monocytes (CBMs) stimulated by 1.25 dihydroxyvitamin D3, but these cells lack the ability to form bone resorption pits, the defining functional characteristic of mature OCs. CBMs may thus require additional stimulation to form OCs; we therefore investigated whether GCTBs are a source of such a stimulus. CBMs were stimulated in long term (21 day) culture by medium conditioned by explants of GCTBs; media collected within 15 days of explant (early-CM) and after 15 days (late-CM) were employed. We also cocultured CBMs with primary GCTB-derived stromal cells as well as immortalized bone marrow stroma-derived cells. CBMs stimulated by early-CM formed resorption pits on cortical bone slices; however, stimulation by late-CM resulted in virtually no resorption. Both early-CM and late-CM increased CBM proliferation, but not the proportion of vitronectin receptor positive or multinucleated cells. Coculture of CBMs with stromal cells of GCTBs or bone marrow did not result in bone resorption, although these stromal cells (most expressing alkaline phosphatase but progressively losing parathyroid hormone receptor expression) expressed mRNA for cytokines involved in OC differentiation, including macrophage-CSF, granulocyte-macrophage-CSF, IL-11, IL-6, and stem cell factor. Our results indicate that CBMs are capable of terminal OC differentiation in vitro, a process requiring 1,25 dihydroxyvitamin D3 as well as diffusible factor(s) which can be derived from GCTB. Stromal cells of GCTB may produce such factors in vivo, but do not support OC differentiation in vitro, possibly through phenotypic instability in culture.
authors.affiliation: Inserm U349 Hôpital Lariboisíere Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Roux
authors.forename: J
authors.initials: J
authors.lastname: Quinn
authors.forename: F
authors.initials: F
authors.lastname: Pichaud
authors.forename: P
authors.initials: P
authors.lastname: Orcel
authors.forename: E
authors.initials: E
authors.lastname: Chastre
authors.forename: A
authors.initials: A
authors.lastname: Jullienne
authors.forename: M C
authors.initials: MC
authors.lastname: De Vernejoul
mesh_terms: D000135:Acid Phosphatase / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D001483:Base Sequence; D001859:Bone Neoplasms / Q000473:pathology*; D001862:Bone Resorption; D002454:Cell Differentiation; D016207:Cytokines / Q000235:genetics; D017931:DNA Primers / Q000737:chemistry; D005312:Fetal Blood / Q000166:cytology*; D005870:Giant Cell Tumors / Q000473:pathology*; D006801:Humans; D008969:Molecular Sequence Data; D009000:Monocytes / Q000166:cytology*; D015675:Osteocalcin / Q000378:metabolism; D010010:Osteoclasts / Q000166:cytology*; D010014:Osteolysis; D018016:Receptors, Parathyroid Hormone / Q000502:physiology; D014407:Tumor Cells, Cultured
chemical_list: D016207:Cytokines; D017931:DNA Primers; D018016:Receptors, Parathyroid Hormone; D015675:Osteocalcin; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase